Fibroblasts Eotaxin-1 Production in Human Airway and IL-13 Synergistically Increase β TGF-Hong

[1]  S. Wenzel,et al.  Expression and activation of 15‐lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  Tak H. Lee,et al.  Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. , 2002, American journal of respiratory and critical care medicine.

[3]  J. Rosenbloom,et al.  Transforming Growth Factor- β Stabilizes Elastin mRNA by a Pathway Requiring Active Smads, Protein Kinase C- δ , and p38 , 2002 .

[4]  P. Foster,et al.  Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. , 2001, American journal of respiratory cell and molecular biology.

[5]  P. Foster,et al.  IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. , 2001, The Journal of allergy and clinical immunology.

[6]  R. Homer,et al.  Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.

[7]  V. Casolaro,et al.  Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. , 2001, American journal of respiratory cell and molecular biology.

[8]  M. Woisetschläger,et al.  STAT6 Mediates Eotaxin-1 Expression in IL-4 or TNF-α-Induced Fibroblasts , 2001, The Journal of Immunology.

[9]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[10]  S. Wenzel,et al.  Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. , 2000, The Journal of allergy and clinical immunology.

[11]  Hirai,et al.  Interleukin‐13 and tumour necrosis factor‐α synergistically induce eotaxin production in human nasal fibroblasts , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[13]  Q. Hamid,et al.  Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. , 1999, American journal of respiratory and critical care medicine.

[14]  W. Paul,et al.  The IL-4 receptor: signaling mechanisms and biologic functions. , 1999, Annual review of immunology.

[15]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[16]  C. Bruijnzeel-Koomen,et al.  Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4 -induced priming of chemotactic responses and induction of PI-3 kinase activity. , 1998, American journal of respiratory cell and molecular biology.

[17]  R. Martin,et al.  Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.

[18]  E. Bröcker,et al.  Interleukin‐13 selectively induces monocyte chemoattractant protein‐1 synthesis and secretion by human endothelial cells. Involvement of IL‐4Rα and Stat6 phosphorylation , 1997, Immunology.

[19]  S. Durham,et al.  Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. , 1997, Journal of immunology.

[20]  S. Durham,et al.  Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. , 1997, The Journal of allergy and clinical immunology.

[21]  R. Martin,et al.  Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. , 1997, American journal of respiratory and critical care medicine.